Illexcor Therapeutics
PrivateLast Round
Seed Round
May 8, 2026
Total Funding Raised
$5.35M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Illexcor Therapeutics is a biotechnology company that develops oral therapies for sickle cell disease and other hematologic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Illexcor Therapeutics Comparables
Compare Illexcor Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cardurion Pharmaceuticals | 77% | |
| Pfizer | 76% | |
| Fulcrum Therapeutics, Inc. | 74% |
Illexcor Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | May 8, 2026 | ||||
| Seed | Mar 12, 2025 |
Key People
Founding team and executive leadership
Illexcor Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Zynext Ventures | Seed |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 8, 2026
$13M raised in Seed Round.
- Mar 12, 2025
Seed round led by Zynext Ventures.
Illexcor Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Illexcor Therapeutics's valuation, stock price, and market status.
Is Illexcor Therapeutics a public or private company?
Illexcor Therapeutics is a private company.
What is the current stock price of Illexcor Therapeutics?
Illexcor Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Illexcor Therapeutics worth (valuation)?
Valuation information for Illexcor Therapeutics is not publicly available.
Can I buy Illexcor Therapeutics stock?
Illexcor Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Illexcor Therapeutics's last funding round?
Illexcor Therapeutics's most recent funding round was Seed Round on May 8, 2026.
Who are the main investors in Illexcor Therapeutics?
Key investors in Illexcor Therapeutics include Zynext Ventures.
Will Illexcor Therapeutics IPO soon?
No public IPO plans have been announced for Illexcor Therapeutics.
How can I track Illexcor Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Illexcor Therapeutics's secondary market activity and sign up for updates.